Bethan Hughes. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralClinical Trials, Phase III as TopicHumansImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useMultiple Sclerosis, Chronic Progressive/drug therapyMultiple Sclerosis, Chronic Progressive/physiopathologyMultiple Sclerosis, Relapsing-Remitting/drug therapyMultiple Sclerosis, Relapsing-Remitting/physiopathology
Substances： See more » Immunosuppressive Agents
Year: 2009 PMID： 19876030 DOI： 10.1038/nrd3043
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694